Supernus Pharmaceuticals (SUPN) Times Interest Earned (2011 - 2023)

Supernus Pharmaceuticals (SUPN) has 13 years of Times Interest Earned data on file, last reported at -$19.33 in Q2 2023.

• Times Interest Earned for Q2 2023 came in at -$19.33, down 408.31% year-over-year; the trailing twelve-month figure through Mar 2024 was -$14.94 (down 300.91% YoY), and the FY2023 annual result was -$2.18, down 133.44% from the prior year.
• Times Interest Earned eased to -$19.33 in Q2 2023 per SUPN's latest filing, from $3.44 in the prior quarter.
• Over five years, Times Interest Earned peaked at $21.54 in Q4 2022 and troughed at -$19.33 in Q2 2023.
• A 5-year average of $4.58 and a median of $5.87 in 2021 frame the typical range for Times Interest Earned.
• The sharpest annual moves came in 2022 and 2023: Times Interest Earned surged 1996.02% in 2022, then slumped 408.31% in 2023.
• A 5-year view of Times Interest Earned shows it stood at $7.07 in 2019, then decreased by 0.17% to $7.05 in 2020, then sank by 85.43% to $1.03 in 2021, then surged by 1996.02% to $21.54 in 2022, then plunged by 189.73% to -$19.33 in 2023.
• Business Quant data shows SUPN's Times Interest Earned at -$19.33 in Q2 2023, $3.44 in Q1 2023, and $21.54 in Q4 2022.